September 7, 2023

Macrophage migration inhibitory factor exacerbates asthmatic airway remodeling via dynamin-related protein 1-mediated autophagy activation


Respiratory Research volume 24, Article number: 216 (2023)
 

Abstract

Background

Macrophage migration inhibitory factor (MIF) and GTPase dynamin-related protein 1 (Drp1)-dependent aberrant mitochondrial fission are closely linked to the pathogenesis of asthma. However, it is unclear whether Drp1-mediated mitochondrial fission and its downstream targets mediate MIF-induced proliferation of airway smooth muscle cells (ASMCs) in vitro and airway remodeling in chronic asthma models. The present study aims to clarify these issues.

September 5, 2023

Intestinal Candida albicans overgrowth in IgA deficiency

Moreno-Sabater A, Sterlin D, Imamovic L et al.  J Allergy Clin Immunol. 2023 May 9:S0091-6749(23)00566-3. doi: 10.1016/j.jaci.2023.03.033. 

Background

Secretory IgA interacts with commensal bacteria, but its impact on human mycobiota ecology has not been widely explored. In particular, whether human IgA-deficiency is associated with gut fungal dysbiosis remains unknown.

Objectives

Our goal was to study the impact of IgA on gut mycobiota ecology.

Methods

The Fungi-Flow method was used to characterize fecal, systemic, and maternal IgA, IgM, and IgG responses against 14 representative fungal strains (yeast/spores or hyphae forms) in healthy donors (HDs) (n = 34, 31, and 20, respectively) and to also compare gut mycobiota opsonization by secretory antibodies in HDs (n = 28) and patients with selective IgA deficiency (SIgAd) (n = 12).

September 2, 2023

Delayed gut microbiota maturation in the first year of life is a hallmark of pediatric allergic disease

Nature Communications volume 14, Article number: 4785 (2023) 

Functional differences within the early-life gut microbiome of infants later diagnosed with atopic diseases.
Allergic diseases affect millions of people worldwide. An increase in their prevalence has been associated with alterations in the gut microbiome, i.e., the microorganisms and their genes within the gastrointestinal tract. Maturation of the infant immune system and gut microbiota occur in parallel; thus, the conformation of the microbiome may determine if tolerant immune programming arises within the infant. Here we show, using deeply phenotyped participants in the CHILD birth cohort (n = 1115), that there are early-life influences and microbiome features which are uniformly associated with four distinct allergic diagnoses at 5 years: atopic dermatitis (AD, n = 367), asthma (As, n = 165), food allergy (FA, n = 136), and allergic rhinitis (AR, n = 187). In a subset with shotgun metagenomic and metabolomic profiling (n = 589), we discover that impaired 1-year microbiota maturation may be universal to pediatric allergies (AD p = 0.000014; As p = 0.0073; FA p = 0.00083; and AR p = 0.0021).

Development of the early-life gut microbiome and associations with eczema in a prospective Chinese cohort.


Cheung MK, Leung TF, Tam WH, Leung ASY, Chan OM, Ng RWY, Yau JWK, Yuen LY, Tong SLY, Ho WCS, Yeung ACM, Chen Z, Chan PKS. 
mSystems. 2023 Aug 30:e0052123. doi: 10.1128/msystems.00521-23. 

ABSTRACT

Alterations in the taxonomic composition and alpha and
 beta diversities of the gut microbiota across the first 3
years of life.
The first few years of life is a key period for the development of the gut microbiome. However, our current understanding of this topic is largely biased toward Western populations. In this study, we characterized the development and determinants of the gut microbiome in a prospective cohort of 112 term Chinese children by sequencing 713 stool samples collected at nine time points from birth to 3 years of age using 16S rRNA gene sequencing. We revealed alterations in the composition and alpha and beta diversities of the gut microbiota across the first 3 years of life. We identified mode of delivery, feeding mode, and intrapartum antibiotics as the major determinants of the early-life gut microbiome, the effects of all of which persisted up to 12 months. Importantly, by conducting a nested case–control study, we showed that alterations in the infant gut microbiota precede the development of eczema.

September 1, 2023

TSLP and asthma: fellow travelers

Open Access
Mini Review




David El-Qutob 1†* 
 

Abstract

The incidence of asthma, a heterogeneous inflammatory disease affecting over 300 million people worldwide, continues to increase in developed countries. Human epithelial cells (ECs) express the alarmin-type cytokine thymic stromal lymphopoietin (TSLP) following tissue injury triggered by several environmental insults, which include allergens, smoke, pollutants, or other irritants.

August 30, 2023

Current state and prospects of artificial intelligence in allergy

van Breugel M, Fehrmann RSN, Bügel M, Rezwan FI, Holloway JW, Nawijn MC, Fontanella S, Custovic A, Koppelman GH.  Allergy. 2023 Aug 16. doi: 10.1111/all.15849. 

Abstract

The field of medicine is witnessing an exponential growth of interest in artificial intelligence (AI), which enables new research questions and the analysis of larger and new types of data. Nevertheless, applications that go beyond proof of concepts and deliver clinical value remain rare, especially in the field of allergy.

This narrative review provides a fundamental understanding of the core concepts of AI and critically discusses its limitations and open challenges, such as data availability and bias, along with potential directions to surmount them.

Current practices and future trends in cockroach allergen immunotherapy

Reginald K, Chew FT. Mol Immunol. 2023 Sep;161:11-24.

Highlights

• Immunotherapy is an appealing long-term solution for treating cockroach allergies as they are difficult to eliminate.

• Using recombinant allergens for allergen immunotherapy improves the reproducibility of treatment outcomes.

• Cockroach allergens can be made even safer for immunotherapy by removing its IgE-epitopes while retaining antigenicity.

• Immunotherapy based on cross-reacting allergen groups should be considered for certain allergens.

• Accurate patient selection via precision allergen testing is the first step towards precision AIT.

Abstract

Purpose of review

This review evaluates the current modes of allergen-specific immunotherapy for cockroach allergens, in terms of clinical outcomes and explores future trends in the research and development needed for a more targeted cockroach immunotherapy approach with the best efficacy and minimum adverse effects.

August 29, 2023

The role of basophil activation test and component-resolved diagnostics in the workup of egg allergy in children at low risk for severe allergic reactions: A real-life study

ORIGINAL ARTICLE
Open Access